Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Cemiplimab & Basal-cell Carcinoma / Basal Cell Cancer (BCC), Cemiplimab is approved by both the FDA and EMA for adults with locally advanced or metastatic Basal-cell Carcinoma / Basal Cell Cancer (BCC) who have previously been treated with a hedgehog pathway inhibitor (HHI) or for whom an HHI is not appropriate (1, 2, 3). Cemiplimab is the first FDA (2021) approved [anti-PD-1 antagoni…